Loading...
Derniers dépôts
-
Hubert Smeets, Bram Verbrugge, Xavier Bulbena, Liliya Hristova, Julia Vogt, et al.. European Joint Programme on Rare Diseases workshop: LAMA2-muscular dystrophy: paving the road to therapy March 17–19, 2023, Barcelona, Spain. LAMA2-muscular dystrophy: paving the road to therapy, Neuromuscular Disorders, 36, pp.16 - 22, 2024, ⟨10.1016/j.nmd.2024.01.001⟩. ⟨hal-04546346⟩
-
Medhi Hassani, Dylan Moutachi, Mégane Lemaitre, Alexis Boulinguiez, Denis Furling, et al.. Beneficial effects of resistance training on both mild and severe mouse dystrophic muscle function as a preclinical option for Duchenne muscular dystrophy. PLoS ONE, 2024, 19, ⟨10.1371/journal.pone.0295700⟩. ⟨hal-04501283⟩
-
Pierre Joanne, Yeranuhi Hovhannisyan, Alexandre Simon, Gaëlle Revet, Romain Diot, et al.. Generation of human induced pluripotent stem cell lines from five patients with Myofibrillar myopathy carrying different heterozygous mutations in the DES gene. Stem Cell Research, 2024, 76, pp.103338. ⟨10.1016/j.scr.2024.103338⟩. ⟨hal-04466294⟩
-
Pascal Laforêt, Michio Inoue, Evelyne Goillot, Claire Lefeuvre, Umut Cagin, et al.. Deep morphological analysis of muscle biopsies from type III glycogenesis (GSDIII), debranching enzyme deficiency, revealed stereotyped vacuolar myopathy and autophagy impairment. Acta Neuropathologica Communications, 2019, 7 (1), ⟨10.1186/s40478-019-0815-2⟩. ⟨hal-02414161⟩
-
Florence Boisgérault, Amine Meliani, Romain Hardet, Solenne Marmier, Fanny Collaud, et al.. Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration. Nature Communications, 2018, 9 (1), pp.4098. ⟨10.1038/s41467-018-06621-3⟩. ⟨hal-02177709⟩
-
Luce Barbat Du Closel, Nathalie Bonello-Palot, Yann Pereon, Andoni Echaniz-Laguna, Jean Philippe Camdessanche, et al.. Clinical and electrophysiological characteristics of women with X-linked Charcot-Marie-Tooth disease. European Journal of Neurology, 2023, 30 (10), pp.3265-3276. ⟨10.1111/ene.15937⟩. ⟨hal-04254200⟩
-
Lidia Almenara-Fuentes, Silvia Rodriguez-Fernandez, Estela Rosell-Mases, Katerina Kachler, Axel You, et al.. A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens. Nanomedicine: Nanotechnology, Biology and Medicine, 2023, pp.102635. ⟨10.1016/j.nano.2022.102635⟩. ⟨hal-03885962⟩
Nombre de documents
773
Nombre de notices
1 376
widget_cloud
Motoneuron
Neuromuscular diseases
Myositis
Myopathy
Cardiomyopathy
Transcriptomics
LMNA
LMNA gene
Neuromuscular disease
COVID-19
Muscle regeneration
Cytokines
Myotonic Dystrophy type 1
Myasthenia gravis
Errance diagnostique
PABPN1
FSHD
Congenital myopathy
DMD
Animals
Autoimmunity
Myotonic dystrophy type 1
Humans
Thymus
CMS
Gene therapy
Laminopathie
Mouse model
CTG repeat contractions
Clinical trials
Neuromuscular junction
Satellite cells
Myasthenia Gravis MG
Astrocyte
Diagnosis
Myotonic dystrophy
Cell therapy
Transgenic mouse model
Myotonic Dystrophy
Dynamin 2
Antisense oligonucleotides
Fabry disease
Laminopathy
ALS
Cancer
RNA interference
Thérapie génique
AAV
Myogenesis
Autoantibodies
Skeletal muscle
Amyotrophic lateral sclerosis
CRISPRi
Lamin A/C
Duchenne muscular dystrophy
Outcome measures
Biomarker
OPMD
Long read sequencing
Muscular dystrophy
Centronuclear myopathy
Aging
Nuclear envelope
Brain
Autoimmune diseases
Treatment
Trinucleotide repeat expansion
Laminopathies
Becker muscular dystrophy
Genotype phenotype correlation
Exercise
Heart
Calcium
Muscle
Heart failure
Satellite cell
Mechanotransduction
Dermatomyositis
Alternative splicing
Myopathies
Actin
Rare neuromuscular diseases
Myoblasts
MBNL
Therapy
Regeneration
Lamin A/C LMNA gene
Fibrosis
Congenital muscular dystrophy
Biomarkers
Glutamate
RNA biology
Autophagy
Aged
Rare diseases
Male
Dilated cardiomyopathy
Cytoskeleton
Dystrophin
Inflammation